Show simple item record

Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers

dc.contributor.authorChang, K-Y
dc.contributor.authorChiang, N-J
dc.contributor.authorWu, S-Y
dc.contributor.authorYen, C-J
dc.contributor.authorChen, S-H
dc.contributor.authorYeh, Y-M
dc.contributor.authorLi, C-F
dc.contributor.authorFeng, X
dc.contributor.authorWu, K
dc.contributor.authorJohnston, A
dc.contributor.authorBomalaski, JS
dc.contributor.authorWu, B-W
dc.contributor.authorGao, J
dc.contributor.authorSubudhi, SK
dc.contributor.authorKaseb, AO
dc.contributor.authorBlando, JM
dc.contributor.authorYadav, SS
dc.contributor.authorSzlosarek, PW
dc.contributor.authorChen, L-T
dc.date.accessioned2021-07-30T15:33:45Z
dc.date.available2021-07-30T15:33:45Z
dc.date.issued2021-01-01
dc.identifier.citationKwang-Yu Chang, Nai-Jung Chiang, Shang-Yin Wu, Chia-Jui Yen, Shang-Hung Chen, Yu-Min Yeh, Chien-Feng Li, Xiaoxing Feng, Katherine Wu, Amanda Johnston, John S. Bomalaski, Bor-Wen Wu, Jianjun Gao, Sumit K. Subudhi, Ahmed O. Kaseb, Jorge M. Blando, Shalini S. Yadav, Peter W. Szlosarek & Li-Tzong Chen (2021) Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers, OncoImmunology, 10:1, DOI: 10.1080/2162402X.2021.1943253en_US
dc.identifier.issn2162-4011
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/73337
dc.format.extent1943253 - ?
dc.publisherTaylor & Francisen_US
dc.relation.ispartofOncoImmunology
dc.rightsCreative Commons Attribution-NonCommercial License
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.titlePhase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancersen_US
dc.typeArticleen_US
dc.rights.holder© 2021 The Author(s).
dc.identifier.doi10.1080/2162402x.2021.1943253
pubs.issue1en_US
pubs.notesNot knownen_US
pubs.volume10en_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US


Files in this item

Thumbnail
Name:
Chang-Phase 1b study ADI-PEG ...
Size:
2.091Mb
Format:
application/
Description:
Published version
View/Open

This item appears in the following Collection(s)

Show simple item record

Creative Commons Attribution-NonCommercial License
Except where otherwise noted, this item's license is described as Creative Commons Attribution-NonCommercial License